16-88707117-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001012759.3(CTU2):c.69-19C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00482 in 1,612,104 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0037 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0049 ( 19 hom. )
Consequence
CTU2
NM_001012759.3 intron
NM_001012759.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.715
Publications
1 publications found
Genes affected
CTU2 (HGNC:28005): (cytosolic thiouridylase subunit 2) This gene encodes a protein which is involved in the post-transcriptional modification of transfer RNAs (tRNAs). The encoded protein plays a role in thiolation of uridine residue present at the wobble position in a subset of tRNAs, resulting in enhanced codon reading accuracy. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
CTU2 Gene-Disease associations (from GenCC):
- microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndromeInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 16-88707117-C-T is Benign according to our data. Variant chr16-88707117-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 1600007.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00365 (556/152260) while in subpopulation NFE AF = 0.00594 (404/68016). AF 95% confidence interval is 0.00546. There are 3 homozygotes in GnomAd4. There are 238 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTU2 | NM_001012759.3 | c.69-19C>T | intron_variant | Intron 1 of 14 | ENST00000453996.7 | NP_001012777.1 | ||
CTU2 | NM_001318507.2 | c.69-19C>T | intron_variant | Intron 1 of 14 | NP_001305436.1 | |||
CTU2 | NM_001012762.3 | c.69-19C>T | intron_variant | Intron 1 of 13 | NP_001012780.1 | |||
CTU2 | NM_001318513.2 | c.-114-19C>T | intron_variant | Intron 1 of 13 | NP_001305442.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00365 AC: 556AN: 152142Hom.: 3 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
556
AN:
152142
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00371 AC: 929AN: 250740 AF XY: 0.00356 show subpopulations
GnomAD2 exomes
AF:
AC:
929
AN:
250740
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00494 AC: 7217AN: 1459844Hom.: 19 Cov.: 30 AF XY: 0.00485 AC XY: 3521AN XY: 726036 show subpopulations
GnomAD4 exome
AF:
AC:
7217
AN:
1459844
Hom.:
Cov.:
30
AF XY:
AC XY:
3521
AN XY:
726036
show subpopulations
African (AFR)
AF:
AC:
28
AN:
33452
American (AMR)
AF:
AC:
130
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
AC:
4
AN:
26122
East Asian (EAS)
AF:
AC:
1
AN:
39636
South Asian (SAS)
AF:
AC:
316
AN:
86216
European-Finnish (FIN)
AF:
AC:
62
AN:
53198
Middle Eastern (MID)
AF:
AC:
20
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
6376
AN:
1110426
Other (OTH)
AF:
AC:
280
AN:
60320
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
378
756
1135
1513
1891
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00365 AC: 556AN: 152260Hom.: 3 Cov.: 33 AF XY: 0.00320 AC XY: 238AN XY: 74430 show subpopulations
GnomAD4 genome
AF:
AC:
556
AN:
152260
Hom.:
Cov.:
33
AF XY:
AC XY:
238
AN XY:
74430
show subpopulations
African (AFR)
AF:
AC:
35
AN:
41558
American (AMR)
AF:
AC:
40
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5172
South Asian (SAS)
AF:
AC:
10
AN:
4822
European-Finnish (FIN)
AF:
AC:
10
AN:
10608
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
404
AN:
68016
Other (OTH)
AF:
AC:
10
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
28
56
84
112
140
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome Benign:1
Nov 18, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.